Minimal residual disease detected by immunoglobulin sequencing predicts CLL relapse more effectively than flow cytometry

Leuk Lymphoma. 2018 Aug;59(8):1986-1989. doi: 10.1080/10428194.2017.1397664. Epub 2017 Nov 22.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Flow Cytometry / methods*
  • Humans
  • Immunoglobulins / genetics*
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Neoplasm, Residual / diagnosis
  • Neoplasm, Residual / genetics*
  • Prognosis
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Sequence Analysis, DNA / methods*
  • Survival Analysis

Substances

  • Immunoglobulins